Is Quoin Pharmaceuticals Ltd DRC (QNRX) overvalued? · $9.6M cap
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
This page asks whether Quoin Pharmaceuticals Ltd DRC (QNRX) looks expensive on cached numbers — not a short thesis.
No cached income statement for QNRX, so there is no earnings base to call rich or cheap.
QNRX currently screens at market cap $9.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next QNRX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the QNRX stock page for the full model, not this heading.
Not investment advice.